HAVRIX adult vaccine 1440 UNT in 1 mL Injection
RxNorm 1658060
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1658060 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: HAVRIX adult vaccine 1440 UNT in 1 mL Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SY
Synonym (SY):
1 mL Havrix 1440 UNT/ML Injection
(Atom ID: 7252240)
SBD
Semantic Branded Drug (SBD):
1 mL hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML Injection [Havrix]
(Atom ID: 12361429)
SY
Synonym (SY):
Havrix 1440 UNT per 1 mL Injection
(Atom ID: 7252252)
PSN
Prescribable Name (PSN):
HAVRIX adult vaccine 1440 UNT in 1 mL Injection
(Atom ID: 7253646)
Patient Education
Hepatitis A Vaccine
Why get vaccinated against hepatitis A? Hepatitis A is a serious liver disease. It is caused by the hepatitis A virus (HAV). HAV is spread from person to person through contact with the feces (stool) of people who are infected, which can easily happen if someone does not wash his or her hands properly. You can also get hepatitis A from food, water, or objects contaminated with HAV. Symptoms of hepatitis A can include the following: fever, fatigue, loss of appetite, nausea, vomiting, and/or joint pain severe stomach pains and diarrhea (mainly in children) jaundice (yellow skin or eyes, dark urine, clay-colored bowel movements) These symptoms usually appear 2 to 6 weeks after exposure and usually last less than 2 months, although some people can be ill for as long as 6 months. If you have hepatitis A you may be too ill to work. Children often do not have symptoms, but most adults do. You can spread HAV without having symptoms. Hepatitis A can cause liver failure and death, although this is rare and occurs more commonly in persons 50 years of age or older and persons with other liver diseases, such as hepatitis B or C. Hepatitis A vaccine can prevent hepatitis A. Hepatitis A vaccines were recommended in the United States beginning in 1996. Since then, the number of cases reported each year in the United States has dropped from around 31,000 cases to fewer than 1,500 cases.
[Learn More]
* Please review the disclaimer below.
